JERSEY CITY, NJ--(Marketwire - October 14, 2008) - QUMAS, a leading provider of regulatory compliance solutions, today announced that Avigen, a biopharmaceutical company developing innovative therapeutics for the treatment of chronic neurological conditions, has selected QUMAS as its document management partner of choice. In phase one of the project, Avigen will implement QUMAS DocCompliance™ as its regulatory content management system for quality assurance and document control. In phase two of the project, Avigen will extend the implementation to meet its regulatory affairs requirements.
